CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $182,793
- in 3 filings
Net −$182,793. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 8 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-26 | Schoenberg Mark Chief Medical Officer | Sale | −103 | $15.30 | $2K | 20,821 |
| 2021-07-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −208 | 417 | ||
| 2021-06-07 | Cohen Fred E Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-07 | BUTITTA CYNTHIA M Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-07 | FALBERG KATHRYN E Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-07 | Tomasello Shawn Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-07 | Nussbaum Ran Director | Grant or award · Stock Option (right to buy) | +6,817 | 6,817 | ||
| 2021-06-07 | Nussbaum Ran Director | Grant or award · Stock Option (right to buy) | +3,183 | 3,183 | ||
| 2021-06-07 | Belldegrun Arie Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-07 | Holden Stuart Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2021-06-05 | Smith Jason Drew General Counsel | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-06-05 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2021-05-19 | Barrett Elizabeth A. Chief Executive Officer | Shares withheld for taxes | −2,185 | $17.51 | $38K | 240,739 |
| 2021-05-19 | Barrett Elizabeth A. Chief Executive Officer | Shares withheld for taxes | −1,240 | $17.51 | $22K | 239,499 |
| 2021-05-17 | Henderson Molly Chief Financial Officer | Purchase | +2,500 | $15.85 | $40K | 2,500 |
| 2021-05-17 | Smith Jason Drew General Counsel | Purchase | +2,500 | $15.71 | $39K | 2,500 |
| 2021-04-30 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +500 | 21,375 | ||
| 2021-04-30 | Schoenberg Mark Chief Medical Officer | Sale | −243 | $20.00 | $5K | 21,132 |
| 2021-04-30 | Schoenberg Mark Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −500 | 3,500 | ||
| 2021-04-26 | Schoenberg Mark Chief Medical Officer | Exercise or conversion | +209 | 20,964 |
Page 16 of 25 · 496 trades